Abstract
There is a need for blood glucose monitoring techniques that eliminate the painful and invasive nature of current methods, while maintaining the reliability and accuracy of established medical technology. This research aims to ultimately address these shortcomings in critically ill pediatric patients. Presented in this work is an alternative, minimally invasive technique that uses microneedles (MN) for the collection of transdermal glucose (TG). Due to their comparable skin properties, diffusion studies were performed on full thickness Yucatan miniature pig skin mounted to an in-line diffusion flow cell and on different skin sites of human subjects. Collected TG samples were measured with a L255C mutant of the E. coli glucose-binding protein (GBP) with an attached fluorescent probe. The binding constant (Kd = 0.67 μM) revealed the micromolar sensitivity and high selectivity of the his-tagged GBP biosensor for glucose, making it suitable for TG measurements. In both the animal and human models, skin permeability and TG diffusion across the skin increased with MN application. For intact and MN-treated human skin, a significant positive linear correlation (r > 0.95, p < 0.01) existed between TG and BG. The micromolar sensitivity of GBP minimized the volume required for interstitial fluid glucose analysis allowing MN application time (30 s) to be shortened compared to other studies. This time reduction can help in eliminating skin irritation issues and improving practical use of the technique by caregivers in the hospital. In addition, the his-tagged optical biosensor used in this work can be immobilized and used with a portable sensing fluorometer device at the point of care (POC) making this minimally invasive technology more ideal for use in the pediatric intensive care unit.

ᅟ









Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.Notes
Receiver and donor solutions are conventional designations for in vitro topical drug delivery experiments where the drug (donor) diffuses from the epidermal side of the skin to the flow solution (receiver). In our experiments, glucose diffuses from the flow solution to the epidermal side.
References
Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee W, et al. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:118–33. https://doi.org/10.1111/j.1399-5448.2009.00569.x.
Piper HG, Alexander JL, Shukla A, Pigula F, Costello JM, Laussen PC, et al. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics. 2006;118(3):1176–84. http://www.ncbi.nlm.nih.gov/pubmed/16951013
Allen HF, Rake A, Roy M, Brenner D, McKiernan CA. Prospective detection of hyperglycemia in critically ill children using continuous glucose monitoring*. Pediatr Crit Care Med. 2008;9(2):153–8. https://insights.ovid.com/crossref?an=00130478-200803000-00003
Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z. Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol. 2009;33(66):1309–18. https://doi.org/10.1177/193229680900300611.
Bridges BC, Preissig CM, Maher KO, Rigby MR. Continuous glucose monitors prove highly accurate in critically ill children https://ccforum.biomedcentral.com/track/pdf/10.1186/cc9280
Barrio Castellanos R, Harris DL, Battin MR, Weston PJ, Harding JE. Continuous glucose monitoring in newborn babies at risk of hypoglycemia. Av en Diabetol. 2010;26(3):209–10. https://doi.org/10.1016/j.jpeds.2010.02.003.
Signal M, Pretty CG, Chase JG, Le Compte A, Shaw GM. Continuous glucose monitors and the burden of tight glycemic control in critical care: can they cure the time cost? J Diabetes Sci Technol. 2010;4(3):625–35. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2901040&tool=pmcentrez&rendertype=abstract
Pretty CG, Chase JG, Le Compte A, Shaw GM, Signal M. Hypoglycemia detection in critical care using continuous glucose monitors: an in silico proof of concept analysis. J Diabetes Sci Technol. 2010;4(1):15–24. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2825620&tool=pmcentrez&rendertype=abstract
Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, Thompson M, Dunger DB. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed. 2005;90(4):F307–10. Available from: http://fn.bmj.com/content/90/4/F307.long
Wintergerst KA, Foster MB, Sullivan JE, Woods CR, Affiliations A. Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit. J Diabetes Sci Technol. 2012;6(1) https://doi.org/10.1177/193229681200600102.
Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics. 2006;118(1):173–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16818563
Ge X, Rao G, Tolosa L. On the possibility of real-time monitoring of glucose in cell culture by microdialysis using a fluorescent glucose binding protein sensor. Biotechnol Prog. 2008;24(3):691–7.
Ge X, Tolosa L, Rao G. Dual-labeled glucose binding protein for ratiometric measurements of glucose. Anal Chem. 2004;76(5):1403–10.
Ge X, Rao G, Kostov Y, Kanjananimmanont S, Viscardi RM, Woo H, et al. Detection of trace glucose on the surface of a semipermeable membrane using a fluorescently labeled glucose-binding protein: a promising approach to noninvasive glucose monitoring. J Diabetes Sci Technol. 2013;7(1):4–12. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3692211&tool=pmcentrez&rendertype=abstract
Ge X, Lam H, Modi SJ, LaCourse WR, Rao G, Tolosa L. Comparing the performance of the optical glucose assay based on glucose binding protein with high-performance anion-exchange chromatography with pulsed electrochemical detection: efforts to design a low-cost point-of-care glucose sensor. J Diabetes Sci Technol. 2007;1(6):864–72.
Fonin AV, Stepanenko OV, Povarova OI, Volova CA, Philippova EM, Bublikov GS, et al. Spectral characteristics of the mutant form GGBP/H152C of D-glucose/D-galactose-binding protein labeled with fluorescent dye BADAN: influence of external factors. PeerJ. 2014;2:e275. Available from: https://peerj.com/articles/275
Khan F, Saxl TE, Pickup JC. Fluorescence intensity- and lifetime-based glucose sensing using an engineered high-Kd mutant of glucose/galactose-binding protein. Anal Biochem. 2010;399(1):39–43. https://www.sciencedirect.com/science/article/pii/S0003269709008112
Joel S, Turner KB, Daunert S. Glucose recognition proteins for glucose sensing at physiological concentrations and temperatures. ACS Chem Biol. 2014;9(7):1595–602. https://doi.org/10.1021/cb500132g.
Quiocho FA. Atomic structures of periplasmic binding proteins and the high-affinity active transport systems in bacteria. Philos Trans R Soc Lond Ser B Biol Sci. 1990;326(1236):341–52. http://www.ncbi.nlm.nih.gov/pubmed/1970641
Ge X, Tolosa L, Simpson J, Rao G. Genetically engineered binding proteins as biosensors for fermentation and cell culture. Biotechnol Bioeng. 2003;84(6):723–31.
Salins LL, Ware RA, Ensor CM, Daunert S. A novel reagentless sensing system for measuring glucose based on the galactose/glucose-binding protein. Anal Biochem. 2001;294(1):19–26.
Kanjananimmanont S, Ge X, Mupparapu K, Rao G, Potts R, Tolosa L. Passive diffusion of transdermal glucose: noninvasive glucose sensing using a fluorescent glucose binding protein. J Diabetes Sci Technol. 2014;8(2):291–8. http://www.ncbi.nlm.nih.gov/pubmed/24876581
Tiangco C, Andar A, Quarterman J, Ge X, Sevilla Iii F, Rao G, et al. Measuring transdermal glucose levels in neonates by passive diffusion: an in vitro porcine skin model. Anal Bioanal Chem. 2017;409:3475–82. https://link.springer.com/content/pdf/10.1007%2Fs00216-017-0289-7.pdf
Khanna P, Strom JA, Malone JI, Bhansali S. Microneedle-based automated therapy for diabetes mellitus. J Diabetes Sci Technol. 2008;2(6):1122–9. Available from: http://dst.sagepub.com/content/2/6/1122.abstract
Teo AL, Shearwood C, Ng KC, Lu J, Moochhala S. Transdermal microneedles for drug delivery applications. Mater Sci Eng B. 2006;132(1–2):151–4.
Yadav JD, Vaidya KA, Kulkarni PR, Raut RA. Microneedles: promising technique for transdermal drug delivery. Int J Pharm Bio Sci. 2011;2:684–708.
Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci. 1998;87(8):922–5. http://linkinghub.elsevier.com/retrieve/pii/S0022354915506242
Wang PM, Cornwell M, Prausnitz MR. Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diabetes Technol Ther. 2005;7(1):131–41. https://doi.org/10.1089/dia.2005.7.131.
Sakaguchi K, Hirota Y, Hashimoto N, Ogawa W, Sato T, Okada S, et al. A minimally invasive system for glucose area under the curve measurement using interstitial fluid extraction technology: evaluation of the accuracy and usefulness with oral glucose tolerance tests in subjects with and without diabetes. Diabetes Technol Ther. 2012;14(6):485–91. https://doi.org/10.1089/dia.2011.0255.
Donnelly RF, Mooney K, Caffarel-Salvador E, Torrisi BM, Eltayib E, McElnay JC. Microneedle-mediated minimally invasive patient monitoring. Ther Drug Monit. 2013; http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00007691-900000000-99442
Romanyuk AV, Zvezdin VN, Samant P, Grenader MI, Zemlyanova M, Prausnitz MR. Collection of analytes from microneedle patches. Anal Chem. 2014;86(21):10520–3. https://doi.org/10.1021/ac503823p.
Caffarel-Salvador E, Brady AJ, Eltayib E, Meng T, Alonso-Vicente A, Gonzalez-Vazquez P, et al. Hydrogel-forming microneedle arrays allow detection of drugs and glucose in vivo: potential for use in diagnosis and therapeutic drug monitoring. Chan C, editor. PLoS One. 2015;10(12):e0145644. Available from: http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0145644&type=printable
Chang H, Zheng M, Yu X, Than A, Seeni RZ, Kang R, et al. A swellable microneedle patch to rapidly extract skin interstitial fluid for timely metabolic analysis. Adv Mater. 2017;29(37):1702243. https://doi.org/10.1002/adma.201702243.
Kiang T, Ranamukhaarachchi S, Ensom M. Revolutionizing therapeutic drug monitoring with the use of interstitial fluid and microneedles technology. Pharmaceutics. 2017;9(4):43. http://www.ncbi.nlm.nih.gov/pubmed/29019915
Zimmermann S, Fienbork D, Stoeber B, Flounders AW, Liepmann D. A microneedle-based glucose monitor: fabricated on a wafer-level using in-device enzyme immobilization. In: TRANSDUCERS’03 12th International Conference on Solid-State Sensors, Actuators and Microsystems Digest of Technical Papers (Cat No03TH8664). IEEE;. p. 99–102. http://ieeexplore.ieee.org/document/1215262/
Zimmermann S, Fienbork D, Flounders AW, Liepmann D. In-device enzyme immobilization: wafer-level fabrication of an integrated glucose sensor. Sensors Actuators B. 2004;99:163–73. Available from: https://ac.els-cdn.com/S0925400503005525/1-s2.0-S0925400503005525-main.pdf?_tid=020881da-3da9-4b06-84bf-c64ada008838&acdnat=1533673088_35e97cd3db5f6bd17c320720a55d18b0
Mukerjee EV, Collins SD, Isseroff RR, Smith RL. Microneedle array for transdermal biological fluid extraction and in situ analysis. Sensors Actuators A. 2004;114:267–75. Available from: https://ac.els-cdn.com/S0924424703006381/1-s2.0-S0924424703006381-main.pdf?_tid=516bf37c-6980-4149-88a5-63fb8c136f85&acdnat=1533668749_77d67ae1d55cee1ddb39130ed33ed624
Strambini LM, Longo A, Scarano S, Prescimone T, Palchetti I, Minunni M, et al. Self-powered microneedle-based biosensors for pain-free high-accuracy measurement of glycaemia in interstitial fluid. 2014; Available from: https://doi.org/10.1016/j.bios.2014.11.010
Sharma S, Huang Z, Rogers M, Boutelle M, Cass AEG. Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring. Anal Bioanal Chem. 2016;408(29):8427–35. https://doi.org/10.1007/s00216-016-9961-6.
Jina A, Tierney MJ, Tamada JA, McGill S, Desai S, Chua B, et al. Design, development, and evaluation of a novel microneedle array-based continuous glucose monitor. J Diabetes Sci Technol. 2014;8(3):483–7. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4455438&tool=pmcentrez&rendertype=abstract
Chua B, Desai SP, Tierney MJ, Tamada JA, Jina AN. Effect of microneedles shape on skin penetration and minimally invasive continuous glucose monitoring in vivo. Sensors Actuators A Phys. 2013;203:373–81. https://doi.org/10.1016/j.sna.2013.09.026.
Lam H, Kostov Y, Rao G, Tolosa L. Low-cost optical lifetime assisted ratiometric glutamine sensor based on glutamine binding protein. Anal Biochem. 2008;383(1):61–7.
Gupta VK, Zatz JL, Rerek M. Percutaneous absorption of sunscreens through micro-Yucatan pig skin in vitro. Pharm Res. 1999;16(10):1602–7. https://doi.org/10.1023/A:1018916907263.
Milewski M. Microneedle-assisted transdermal delivery of naltrexone species: in vitro permeation and in vivo pharmacokinetics studies. Vol. 160. University of Kentucky Doctoral Dissertations; 2011. Available from: https://uknowledge.uky.edu/gradschool_diss/160
Tiangco C, Fon D, Sardesai N, Kostov Y, Sevilla F, Rao G, et al. A fiber optic biosensor for umolar levels of glucose less figures. Sensors Actuators. 2015;
Bhatnagar S, Dave K, Venuganti VVK. Microneedles in the clinic. J Control Release. 2017;260:164–82. Available from: https://www.sciencedirect.com/science/article/pii/S016836591730603X
McCrudden MTC, McAlister E, Courtenay AJ, González-Vázquez P, Raj Singh TR, Donnelly RF. Microneedle applications in improving skin appearance. Exp Dermatol. 2015;24(8):561–6. https://doi.org/10.1111/exd.12723.
Acknowledgements
The authors acknowledge the Eunice Kennedy Shriver National Institute of Child Health and Human Development for grant R41HD088223 and the UMB-UMBC Research and Innovation Partnership Grant Program for project funding, as well as, the UMBC Meyerhoff Graduate Program and LSAMP Bridges to the Doctorate Program for S. Brown’s funding. The authors would like to thank Dr. Russel Potts for invaluable input and Eric Ankers for assistance with experimental work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflict of interest. Yucatan minipig skin was purchased from Sinclair BioResources who comply with multiple agencies and are a USDA licensed breeder (43-A-5793). The company is in full compliance with the Animal Welfare Act and has maintained accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International) since 1995.
The studies on human subjects were conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Office of Research Protections and Compliance of UMBC (Protocol Y17LT05060) on November 9, 2016.
Rights and permissions
About this article
Cite this article
Brown, S., Zambrana, P.N., Ge, X. et al. Minimally invasive technique for measuring transdermal glucose with a fluorescent biosensor. Anal Bioanal Chem 410, 7249–7260 (2018). https://doi.org/10.1007/s00216-018-1336-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-018-1336-8


